Corcept Therapeutics (CORT) Other Gross PP&E Adjustments (2016 - 2026)
Corcept Therapeutics (CORT) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with -$7.6 million as the latest value for Q1 2026.
- For Q1 2026, Other Gross PP&E Adjustments fell 40.49% year-over-year to -$7.6 million; the TTM value through Mar 2026 reached -$7.6 million, down 40.49%, while the annual FY2025 figure was -$32.4 million, 5.9% down from the prior year.
- Other Gross PP&E Adjustments hit -$7.6 million in Q1 2026 for Corcept Therapeutics, up from -$32.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $3.2 million in Q1 2023 and bottomed at -$32.4 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$5.4 million, with a median of -$2.5 million recorded in 2023.
- Year-over-year, Other Gross PP&E Adjustments soared 423.32% in 2023 and then crashed 1119.39% in 2024.
- Corcept Therapeutics' Other Gross PP&E Adjustments stood at $932000.0 in 2022, then tumbled by 369.42% to -$2.5 million in 2023, then plummeted by 1119.39% to -$30.6 million in 2024, then fell by 5.9% to -$32.4 million in 2025, then surged by 76.63% to -$7.6 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$7.6 million, -$32.4 million, and -$5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.